Related Experiment Video
Updated: May 13, 2026
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Optimal time for MRI response evaluation in squamous cell carcinoma of the anus
Bettina A Hanekamp1,2, Ellen Viktil1,2, Johann Baptist Dormagen2
1Institute of Clinical Medicine, University of Oslo, 0318 Oslo, Norway.
Objectives:
To identify the optimal time for MRI response evaluation after chemoradiotherapy (CRT) in squamous cell carcinoma of the anus (SCCA) and to employ combined T2+diffusion-weighted MRI tumour regression grade (comrTRG).
Methods:
We assessed the positive and negative predictive values (PPV, NPV) of post-treatment MRI in a retrospective mono-centre diagnostic accuracy study that prospectively included consecutive patients treated between 2013 and 2017. Index tests were MRI at 6-, 12-, and 24-weeks post-treatment (6w, 12w, and 24w) to detect locoregional treatment failures (LRTF). Clinical outcome served as reference standard. Tumour regression was assessed using comrTRG based on radiological reports. Mixed-effects logistic regression was used to compare the comrTRG score across time points. The analyses were stratified by patients' T/N stage and human papillomavirus (HPV) status.
Results:
For 127 included patients (62 years ± 11 [mean ± SD]; 92 women), 261 post-treatment MRI reports (6w: n = 45, 12w: n = 125, 24w: n = 91) were scored using comrTRG. LRTF occurred in 13 patients; 12/13 were high-risk patients (T3/T4, N+, or HPV-negative); 1/13 progressed early (<24 weeks). The rate of radiologic complete response (comrTRG1) increased over time (6w: 27%, 12w: 66%, 24w: 75%), while the rate of indeterminate (comrTRG2) and minor definite tumour (comrTRG3) decreased. PPV of MRI increased over time: 6w: 33% (95%CI: 9.9%-65.1%), 12w: 46% (16.7%-76.6%), and 24w: 88% (47.3%-99.7%). NPV was stable high >90%.
Conclusions:
MRI performed more reliably after 24 weeks. Timely assessment may aid early LRTF detection. Tailoring follow-up with frequent MRI scans may be sufficient for high-risk patients. Combined mrTRG is practical for describing response in SCCA.
Advances In Knowledge:
Post-treatment MRI assessment at later time points is preferable in SCCA to avoid inconclusive imaging and unnecessary salvage surgery. The introduced comrTRG is a practical tool for response evaluation.
Registration:
ClinicalTrials.gov: NCT01937780.
Related Concept Videos
01:24Magnetic Resonance Imaging
01:21Imaging Studies for Cardiovascular System IV: CMRI
01:27Imaging Studies IV: Magnetic Resonance Imaging